Literature DB >> 16924053

Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.

Betsy N Perry1, Cynthia Cohen, Baskaran Govindarajan, George Cotsonis, Jack L Arbiser.   

Abstract

BACKGROUND: Pigmented lesions are common, yet they present diagnostic and therapeutic challenges. They range from nevi, which are clinically stable, to melanomas, which are notorious for distant metastasis and death. Both nevi and melanomas arise from melanocytes, which are neural crest derivatives, and melanocyte precursors migrate from the paraspinal area to their eventual location at the dermoepidermal junction. Atypical nevi have been clinically considered to be precursors of melanoma, and recently, biochemical abnormalities have been found that are present in both nevi and melanomas, including inactivation of the p16INK4a tumor suppressor gene and mutations in B-raf. These mutations suggest not only that nevi and melanomas share a common origin but also that additional events are required for transformation to malignant melanoma. OBSERVATIONS: We performed a Panomics protein array comparing a radial growth melanoma cell line with a vertical growth melanoma cell line and found that the transcription factor Wilms tumor 1 is highly expressed in the vertical growth cell line compared with the radial growth cell line. Using immunohistochemical analysis, we compared expression of archival nevi and melanomas in a tissue microarray.
CONCLUSION: We found that Wilms tumor 1 is expressed in most melanomas but is nearly absent in nevi. Immunohistochemical analysis for Wilms tumor 1 may be clinically useful in distinguishing nevi from melanoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924053     DOI: 10.1001/archderm.142.8.1031

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  p15 Expression Differentiates Nevus from Melanoma.

Authors:  Laura A Taylor; Conor O'Day; Tzvete Dentchev; Kyle Hood; Emily Y Chu; Todd W Ridky; John T Seykora
Journal:  Am J Pathol       Date:  2016-11-14       Impact factor: 4.307

2.  WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi.

Authors:  Karli Rosner; Darius R Mehregan; Darius Moussai; Judith Abrams; Gerard Tromp; David A Mehregan
Journal:  J Cutan Pathol       Date:  2009-07-09       Impact factor: 1.587

3.  Correlation between the WT1 suppressor gene and skin lesions: an alternative diagnostic-differential factor.

Authors:  Przemysław Gałązka; Kamil Leis; Ewelina Mazur; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.